11.3 Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy

Status Asthmaticus, Pulmonary Edema & ARDS in Pregnancy

Acute respiratory failure in pregnancy is a critical emergency that threatens both maternal and fetal survival. Because fetal oxygenation depends entirely on maternal arterial oxygen tension and uteroplacental perfusion, maternal hypoxemia rapidly translates into profound fetal hypoxia, acidosis, and demise. Understanding the physiologic alterations of the respiratory system in pregnancy, mastering stepwise interventions for severe bronchospasm, and executing lung-protective mechanical ventilation are essential competencies in obstetric critical care.

---

1. Respiratory Physiology of Pregnancy & The "Normal" ABG Trap

Maternal Respiratory Adaptations

• Progesterone-Mediated Hyperventilation: Elevated progesterone stimulates the central medullary respiratory center, increasing tidal volume by 30% to 50% (with minimal change in respiratory rate), leading to an overall 30% to 50% increase in minute ventilation.
• Physiologic Arterial Blood Gas (ABG): The hyperventilation produces a chronic, compensated respiratory alkalosis. Renal bicarbonate excretion compensates by lowering serum bicarbonate to 18–22 mEq/L.
• Reduced Functional Residual Capacity (FRC): Diaphragmatic elevation by the gravid uterus reduces FRC by 20% to 30%, reducing maternal oxygen reserve.
• Increased Oxygen Consumption: Maternal and fetal metabolic demands elevate total oxygen consumption by 20% to 35%.

+---------------------------------------------------------------------------------------------------+
|                    ARTERIAL BLOOD GAS (ABG) INTERPRETATION IN PREGNANCY                           |
|                                                                                                   |
|  PARAMETER          NON-PREGNANT ADULT       NORMAL PREGNANCY          CRITICAL IMPLICATION       |
|  • pH:              7.35 – 7.45              7.40 – 7.45               Maternal target >= 7.30    |
|  • PaCO2:           35 – 45 mmHg             **28 – 32 mmHg**          **PaCO2 >=35 mmHg = FAILURE|
|  • PaO2:            80 – 100 mmHg            **100 – 105 mmHg**        **PaO2 <70 mmHg = HYPOXIA**|
|  • Serum HCO3-:     22 – 26 mEq/L            18 – 22 mEq/L             Reduced buffering capacity |
|  • Base Excess:     -2 to +2 mEq/L           -4 to -2 mEq/L            Narrow acidosis buffer     |
|                                                                                                   |
|  THE "NORMAL" CO2 TRAP:                                                                           |
|  • In a non-pregnant adult, a PaCO2 of 40 mmHg is entirely normal.                                |
|  • In a pregnant patient experiencing an asthma attack, a **PaCO2 of 38–42 mmHg indicates         |
|    SEVERE ALVEOLAR HYPOVENTILATION, RESPIRATORY MUSCLE EXHAUSTION, AND IMPENDING RESPIRATORY      |
|    ARREST!** This represents acute failure of physiological hyperventilation.                     |
+---------------------------------------------------------------------------------------------------+

---

2. Status Asthmaticus: Stepwise Pharmacological Escalation

Asthma complicates approximately 4% to 8% of pregnancies. Severe exacerbations (status asthmaticus) can rapidly cause severe maternal hypoxemia and fetal demise.

+---------------------------------------------------------------------------------------------------+
|                         STEPWISE ESCALATION FOR SEVERE ASTHMA / STATUS                            |
|                                                                                                   |
|  STEP 1: OXYGENATION & INHALED SHORT-ACTING BETA-2 AGONISTS (SABA)                                |
|  • High-flow supplemental O2 via nasal cannula or non-rebreather to maintain **SpO2 >= 95%**      |
|    (or PaO2 >= 70 mmHg) to ensure adequate placental oxygen diffusion.                           |
|  • **Albuterol (2.5 to 5 mg nebulized)** every 20 minutes for 3 doses, or **Continuous Albuterol  |
|    Nebulization at 10 to 15 mg/hour**.                                                            |
|                                                                                                   |
|  STEP 2: INHALED ANTICHOLINERGIC THERAPY                                                          |
|  • **Ipratropium Bromide (0.5 mg nebulized)** combined with albuterol every 20 minutes for 3 doses.|
|  • Synergistic bronchodilation by blocking parasympathetic bronchoconstriction.                   |
|                                                                                                   |
|  STEP 3: SYSTEMIC INTRAVENOUS CORTICOSTEROIDS (EARLY ADMINISTRATION)                              |
|  • **Methylprednisolone 60 mg IV every 6 hours** OR **Hydrocortisone 100 mg IV every 6–8 hours**. |
|  • Oral alternative: Prednisone 40–60 mg PO daily.                                                |
|  • Corticosteroids reduce airway mucosal edema, decrease mucus plugging, and upregulate beta-2    |
|    receptors; systemic steroids are entirely safe in pregnancy and must never be withheld.       |
|                                                                                                   |
|  STEP 4: INTRAVENOUS MAGNESIUM SULFATE FOR REFRACTOSPASM                                         |
|  • **Magnesium Sulfate: 2 g IV in 100 mL D5W or NS infused over 20 minutes**.                     |
|  • Potent bronchial smooth muscle relaxant via calcium channel blockade and inhibition of         |
|    acetylcholine release at motor endplates; highly effective in severe refractory asthma.        |
|                                                                                                   |
|  STEP 5: SUBCUTANEOUS ADRENERGIC RESCUE (MORIBUND PATIENT)                                        |
|  • **Terbutaline 0.25 mg SC every 20 min x 3 doses** OR **Epinephrine 0.3 mg (1:1,000) IM/SC**.    |
|  • Indicated if severe air trapping prevents delivery of inhaled aerosolized nebulizers.          |
+---------------------------------------------------------------------------------------------------+

Indications for Urgent Endotracheal Intubation

• PaCO2 ≥ 35–40 mmHg (pseudonormalization or hypercapnia).
• Refractory severe hypoxemia (PaO2 < 70 mmHg or SpO2 < 95% despite maximal supplemental O2).
• Extreme maternal exhaustion, somnolence, altered mental status, or "silent chest" (absent breath sounds due to critical airflow limitation).
• Severe acidemia (pH < 7.20).

The Pregnant Airway: Critical Intubation Rules

• Obstetric patients have friable, hypervascular, edematous airway mucosa, increased weight, and larger breasts, making them 8 to 10 times more likely to have a failed intubation than non-pregnant patients.
• Use video laryngoscopy, have a difficult airway cart (bougie, supraglottic airway, cricothyrotomy kit) at bedside, choose a smaller endotracheal tube (size 6.0 to 6.5 or 7.0 mm cuffed ETT), pre-oxygenate with 100% O2, and perform rapid sequence intubation (RSI) with continuous cricoid/laryngeal manipulation.

---

3. Pulmonary Edema in Pregnancy: Cardiogenic vs Non-Cardiogenic

Pulmonary edema in pregnancy complicates approximately 0.08% of all deliveries, but occurs in up to 3% to 5% of women with severe preeclampsia.

+---------------------------------------------------------------------------------------------------+
|                         ETIOLOGICAL CLASSIFICATION OF PULMONARY EDEMA                             |
|                                                                                                   |
|  1. NON-CARDIOGENIC PULMONARY EDEMA (CAPILLARY LEAK / ONCOTIC FAILURE):                          |
|     • Preeclampsia / Eclampsia: Severe generalized endothelial dysfunction, increased capillary   |
|       permeability, and severe hypoalbuminemia (colloid oncotic pressure drops from 22 to <14).   |
|     • Tocolytic-Induced: Beta-2 agonists (terbutaline, ritodrine) induce fluid retention,         |
|       exacerbated by concurrent crystalloid hydration and antenatal corticosteroids.              |
|     • Iatrogenic Fluid Overload: Massive IV crystalloid hydration during labor or pre-hydration   |
|       prior to epidural placement; oxytocin infusions in large volumes of hypotonic fluids        |
|       (oxytocin has intrinsic ADH-like antidiuretic properties).                                  |
|     • Sepsis / Chorioamnionitis / Pyelonephritis: Inflammatory cytokine-mediated capillary injury.|
|                                                                                                   |
|  2. CARDIOGENIC PULMONARY EDEMA (HYDROSTATIC FAILURE):                                            |
|     • Peripartum cardiomyopathy, severe preeclamptic afterload crisis / hypertensive emergency,   |
|       uncorrected severe mitral stenosis, aortic valve disease, or acute myocardial infarction.   |
+---------------------------------------------------------------------------------------------------+

Diagnostic Differentiation Table

Emergency Management of Pulmonary Edema

1. Positioning & Supplemental Oxygen: Place the patient in an upright sitting position. Administer high-flow oxygen; apply Non-Invasive Positive Pressure Ventilation (CPAP 5–10 cmH2O or BiPAP) to increase alveolar recruitment, reduce work of breathing, and decrease venous return (preload) and afterload.
2. Loop Diuretics: Furosemide 20 to 40 mg IV push (may repeat at 40–80 mg IV at 1 hour if urine output remains inadequate). Indicated for both cardiogenic failure and hypervolemic non-cardiogenic edema.
3. Vasodilators (for Hypertensive Pulmonary Edema): Intravenous Nitroglycerin (start at 10–20 mcg/min, titrate up to 100–200 mcg/min) or Nicardipine infusion (5 to 15 mg/h). Rapidly reduces preload and afterload.
4. Strict Fluid Restriction: Limit total fluid intake to <80 to 100 mL/hour.

---

4. Acute Respiratory Distress Syndrome (ARDS) in Pregnancy

ARDS is a devastating syndrome of non-cardiogenic pulmonary edema, severe alveolar-capillary barrier disruption, and refractory hypoxemic respiratory failure.

+---------------------------------------------------------------------------------------------------+
|                         BERLIN CRITERIA FOR ARDS IN PREGNANCY                                     |
|                                                                                                   |
|  1. TIMING: Acute onset within 1 week of a known clinical insult or new/worsening symptoms.       |
|  2. CHEST IMAGING: Bilateral opacities on chest radiography or CT not fully explained by          |
|     effusions, lobar collapse, or pulmonary nodules.                                              |
|  3. ORIGIN OF EDEMA: Respiratory failure not fully explained by cardiac failure or fluid overload. |
|  4. OXYGENATION DERANGEMENT (on PEEP >= 5 cmH2O):                                                 |
|     • **Mild ARDS:** 200 mmHg < PaO2 / FiO2 <= 300 mmHg.                                          |
|     • **Moderate ARDS:** 100 mmHg < PaO2 / FiO2 <= 200 mmHg.                                      |
|     • **Severe ARDS:** PaO2 / FiO2 <= 100 mmHg.                                                   |
+---------------------------------------------------------------------------------------------------+

Obstetric Triggers for ARDS

• Amniotic Fluid Embolism (AFE): Sudden anaphylactoid activation and catastrophic pulmonary vasoconstriction.
• Severe Sepsis: Sepsis secondary to chorioamnionitis, septic abortion, acute pyelonephritis, or necrotizing fasciitis.
• Massive Hemorrhage & Transfusion: Transfusion-Related Acute Lung Injury (TRALI) and Transfusion-Associated Circulatory Overload (TACO).
• Aspiration Pneumonitis (Mendelson Syndrome): Aspiration of acidic gastric contents during emergency anesthesia.

Lung-Protective Mechanical Ventilation Protocol

+---------------------------------------------------------------------------------------------------+
|                         LUNG-PROTECTIVE VENTILATION PARAMETERS IN PREGNANCY                       |
|                                                                                                   |
|  1. TIDAL VOLUME (LOW TIDAL VOLUME VENTILATION):                                                  |
|     • Set Tidal Volume (Vt) to **6 mL/kg of Predicted Body Weight (PBW)** (range 4 to 8 mL/kg).    |
|     • **CALCULATE PBW BASED ON MATERNAL HEIGHT, NOT ACTUAL PREGNANT WEIGHT!**                     |
|       - Female PBW (kg) = 45.5 + 0.91 * [Height (cm) - 152.4].                                    |
|       - Using actual pregnant weight results in massive volumetric barotrauma (volutrauma).       |
|                                                                                                   |
|  2. AIRWAY PRESSURES:                                                                             |
|     • Target **Plateau Pressure (Pplat) < 30 cmH2O** (measured during an inspiratory hold).       |
|     • Maintain Driving Pressure (Pplat - PEEP) < 15 cmH2O.                                        |
|                                                                                                   |
|  3. PEEP TITRATION:                                                                               |
|     • Titrate PEEP between **8 and 16 cmH2O** using the ARDSNet PEEP/FiO2 titration grid to        |
|       prevent end-expiratory alveolar collapse (atelectotrauma).                                  |
|                                                                                                   |
|  4. OXYGENATION & BLOOD GAS TARGETS:                                                              |
|     • **Maternal PaO2 Target: >= 70 mmHg (or SpO2 95% to 98%)**.                                  |
|       - Unlike non-pregnant ARDS (where PaO2 55–80 mmHg / SpO2 88–92% is acceptable), pregnancy   |
|         demands higher maternal oxygenation to maintain the transplacental oxygen gradient.       |
|     • **Ventilatory Target (PaCO2): 32 to 40 mmHg**.                                              |
|       - Avoid severe maternal alkalosis (PaCO2 <28 mmHg), which causes uterine artery vasoconstriction|
|         and impairs fetal oxygen unloading (Bohr effect).                                         |
|       - Permissive hypercapnia is allowed cautiously, keeping arterial pH > 7.20 to 7.25.         |
+---------------------------------------------------------------------------------------------------+

Prone Positioning in Obstetric ARDS

• Efficacy: In moderate-to-severe ARDS (PaO2/FiO2 <150), prone positioning for ≥16 hours per day significantly improves ventilation-perfusion matching, promotes dorsal alveolar recruitment, and reduces mortality.
• Pregnancy Execution: Prone ventilation is feasible and safe in all trimesters. Proper positioning requires positioning rolls or specialized padded bolsters beneath the upper chest/shoulders and pelvis to fully suspend the gravid uterus, avoiding aortocaval compression and direct pressure on the fetus.